Governor Newsom’s mental health reform continues to deliver, announcing 15 new projects expanding care across the state - California State Portal | CA.gov

“I am delighted to share the publication of the inaugural issue of OncoIntelligence Journal (Volume 1, Issue 1, 2026), an international, peer-reviewed, open-access scientific journal dedicated to advancing oncology research and innovation. As a member of the Editorial Board, I am pleased to support this new academic initiative, which aims to provide an international platform for researchers, clinicians, and scientists to share their work and contribute to progress in cancer research and care.

What you need to know: First Partner Jennifer Siebel Newsom and Chancellor Marcelo Suárez-Orozco, in patronage of the Pontifical Academy of Social Sciences, convened global scientists, academicians, doctors, faith leaders, state officials, and advocates for a two-day summit exploring opportunities to advance social connection and belonging in a time of uncertainty and division. VATICAN CITY – First Partner Jennifer Siebel Newsom and Chancellor Marcelo Suárez-Orozco, in patronage of the Pontifical Academy of Social Sciences (PASS), co-hosted a two-day international summit at the historic Casina Pio IV at the Vatican last week. The summit brought together cross-sector leaders to confront the growing global crisis of social disconnection, advance a shared agenda to treat social health with the same urgency as physical and mental health, and share all of the programs that California and other communities across the world have modeled to answer this call.

Gov. Gavin Newsom this week claimed a major victory for CARE Court, his program to provide mental health treatment to Californians with serious conditions. Did it really help 10,000 people?” Gov. Gavin Newsom claimed a major victory for his signature mental health court on Thursday, but critics say his math appears more than a little fuzzy.

Bioengineer.org news storyFor people living with HIV, modern antiretroviral therapy can suppress the virus to levels below what standard laboratory tests can detect. Yet some patients on long-term treatment experience a curious phenomenon: a single test result showing a small, transient amount of virus in the blood, followed by an immediate return to undetectable levels. These events, known as viral blips, have puzzled clinicians and researchers for years, raising questions about whether they represent harmless statistical noise, brief bursts of viral production from hidden reservoirs, or early warnings of impending treatment failure. A new nationwide Swedish study, published in BMC Infectious Diseases, offers one of the most comprehensive answers to date. Drawing on the Swedish national InfCareHIV cohort, researchers analyzed data from 4,210 treatment-naïve adults who began antiretroviral therapy from 1 January 2007 onward, with follow-up data extracted through 30 September 2020. The median observation time was 5.5 years, with some individuals followed for as long as 13.7 years.